# Substrate Metabolism, Growth Hormone Signaling (GH), and Insulin Sensitivity During GH and Ketone Bodies Infusion

> **NCT02655263** · NA · COMPLETED · sponsor: **University of Aarhus** · enrollment: 10 (estimated)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Somatropin
- **OTHER:** Ketone bodies

## Key facts

- **NCT ID:** NCT02655263
- **Lead sponsor:** University of Aarhus
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-01
- **Primary completion:** 2017-10
- **Final completion:** 2017-10
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2017-11-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02655263

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02655263, "Substrate Metabolism, Growth Hormone Signaling (GH), and Insulin Sensitivity During GH and Ketone Bodies Infusion". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT02655263. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*